SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Current Federal Tax Expense (Benefit)
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Current Federal Tax Expense (Benefit) of $27.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-03-31
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. current federal tax expense (benefit) for fiscal 2025 was $27.30M, a 157.55% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. current federal tax expense (benefit) for fiscal 2024 was $10.60M, a 76.67% increase from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. current federal tax expense (benefit) for fiscal 2023 was $6.00M.
| Period end | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $27.30M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $10.60M 10-K · filed 2025-02-26 | |
| 2023-12-31 | $6.00M 10-K/A · filed 2024-09-04 | $6.04M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |